Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tiziana Life Sciences PLC

1.57
+0.09006.08%
Post-market: 1.620.0500+3.18%18:46 EDT
Volume:377.22K
Turnover:589.16K
Market Cap:163.28M
PE:-11.77
High:1.60
Open:1.56
Low:1.50
Close:1.48
Loading ...

Tiziana Life Sciences Ltd: Collaboration Aims to Develop a Comprehensive Plan for Scale-up of Foralumab in a Nasal Device

THOMSON REUTERS
·
21 Feb

Tiziana Life Sciences Announces Agreement for Product Development Services With Renaissance Lakewood, Llc

THOMSON REUTERS
·
21 Feb

Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC

GlobeNewswire
·
21 Feb

Tiziana Life Sciences doses additional four patients in multiple sclerosis trial

TIPRANKS
·
18 Feb

Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program

THOMSON REUTERS
·
18 Feb

3 Promising US Penny Stocks With Market Caps Over $20M

Simply Wall St.
·
12 Feb

Tiziana announces TV interview with AD patient dosed with foralumab

TIPRANKS
·
11 Feb

Tiziana Life Sciences Announces Tv Interview With First Patient Dosed With Moderate Alzheimer’s Disease

THOMSON REUTERS
·
11 Feb

Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer’s Disease

GlobeNewswire
·
11 Feb

Tiziana Life Sciences Shares Higher on Positive Results for Spinal Cord Injury Treatment

Dow Jones
·
24 Jan

Tiziana Life Sciences' Foralumab Demonstrates Motor Function Improvement in Preclinical Spinal Cord Injury Studies

MT Newswires Live
·
24 Jan

Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-Cd3

THOMSON REUTERS
·
24 Jan

Tiziana Life Sciences Says it Has No Immediate Capital Raising Plans; Shares Fall

MT Newswires Live
·
23 Jan

Tiziana Life Sciences Not to Engage in Capital Raising Activities for the Immediate Future

THOMSON REUTERS
·
23 Jan

Tiziana Life Sciences not to engage in capital raising activities for the immediate future

GlobeNewswire
·
23 Jan

BRIEF-Tiziana Announces Discovery Of New Immune Biomarkers In Multiple Sclerosis Patients Treated With Nasal Foralumab

Reuters
·
23 Jan